Contact this trialFirst, we need to learn more about you.
Angiotensin Receptor Blocker
Losartan for Cardiovascular Disease
Recruiting2 awardsPhase 4
San Francisco, California
This trial will test if losartan can improve cardiopulmonary outcomes in people with pre-COPD caused by long-term exposure to secondhand tobacco smoke. The trial is double-blind, meaning neither the participants nor the researchers will know who is taking losartan or the placebo until the trial is over.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.